Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue

Diabetes
D G MaggsR S Sherwin

Abstract

We used microdialysis to distinguish the effects of hyperinsulinemia and hypoglycemia on glucose, gluconeogenic substrate, and catecholamine levels in adipose and muscle extracellular fluid (ECF). Ten lean humans (six males and four females) were studied during baseline and hyperinsulinemic (3 mU x kg-1 x min-1 for 3 h) euglycemia (5.0 mmol/l) and hypoglycemia (2.8 mmol/l). In muscle and adipose, basal ECF glucose was lower (muscle, 3.5 +/- 0.2 mmol/l; adipose tissue, 3.3 +/- 0.2 mmol/l) and lactate was higher (muscle, 2.2 +/- 0.2 mmol/l; adipose, 1.5 +/- 0.3 mmol/l) than respective plasma values (glucose, 4.9 +/- 0.1 mmol/l; lactate, 0.7 +/- 0.1 mmol/l), whereas alanine was higher in muscle ECF (379 +/- 22 micromol/l) than adipose tissue (306 +/- 22 micromol/l) and plasma (273 +/- 33 micromol/l). Plasma catecholamines (unchanged during euglycemia) rose during hypoglycemia with epinephrine, increasing approximately fivefold more than norepinephrine. In contrast, the hypoglycemia-induced increments in muscle dialysate norepinephrine and epinephrine were similar, suggesting local generation of norepinephrine. Compared with euglycemia, hypoglycemia produced a greater increase in lactate and a smaller reduction in alanine in muscle...Continue Reading

Citations

Jan 18, 2005·Journal of Neurology·Marie GirotDidier Leys
Sep 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·B E de Galan, J B Hoekstra
Nov 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·W V TamborlaneE Boland
Jun 6, 1998·The New England Journal of Medicine·T W JonesW V Tamborlane
Mar 4, 2005·Treatments in Endocrinology·Samuel Dagogo-Jack
Dec 20, 2007·Clinical Endocrinology·Alia MunirJohn Newell-Price
Jul 16, 2004·Metabolism: Clinical and Experimental·Volker MerlBernd Schultes
Mar 12, 2005·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehia Y Mishriki
Jul 22, 2011·American Journal of Physiology. Cell Physiology·S LivermoreC A Nurse
Apr 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Staffan EnokssonRobert S Sherwin
Mar 14, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Walid M Abi-SaabRobert S Sherwin
Apr 12, 2018·Diabetes Technology & Therapeutics·Vanessa MoscardóPaolo Rossetti
Oct 12, 1999·The American Journal of Physiology·T W LamerisA J Veld
Mar 11, 2004·American Journal of Physiology. Endocrinology and Metabolism·Luiz Carlos C NavegantesIsis C Kettelhut
Apr 6, 2000·Journal of Applied Physiology·V StichF Crampes
Jul 27, 2000·American Journal of Physiology. Endocrinology and Metabolism·B StallknechtH Galbo
Nov 10, 2005·American Journal of Physiology. Endocrinology and Metabolism·Elisabet BørsheimRobert R Wolfe
Mar 10, 1999·The American Journal of Physiology·K Zierler
Nov 14, 1998·The American Journal of Physiology·D S ParamoreP E Cryer

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.